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The ATPase SecA mediates the posttranslational translocation of a
wide range of polypeptide substrates through the SecY channel in
the cytoplasmic membrane of bacteria. We have determined the
crystal structure of a monomeric form of Bacillus subtilis SecA at a
2.2-Å resolution. A comparison with the previously determined
structures of SecA reveals a nucleotide-independent, large confor-
mational change that opens a deep groove similar to that in other
proteins that interact with diverse polypeptides. We propose that
the open form of SecA represents an activated state.
Many polypeptides are exported from bacterial cells aftercompletion of their biosynthesis, employing a posttrans-
lational translocation pathway. N-terminal signal sequences di-
rect polypeptides to the Sec machinery in the cytoplasmic
membrane. The major components of the machinery are the
transmembrane proteins, SecY, SecE, and SecG, which form
the protein-conducting SecY channel, as well as the cytosolic
ATPase SecA (1, 2).
SecA is essential and sufficient to move polypeptides through
the channel, but how it utilizes cycles of ATP hydrolysis to
provide the driving force for translocation is poorly understood.
The currently favored model is a membrane insertion and
deinsertion mechanism in which SecA binds a polypeptide
segment in the cytosol and inserts with it into the channel (3).
Upon ATP hydrolysis, SecA moves back into the cytosol, leaving
the polypeptide segment in the channel, and grabs the next
segment, continuing this process until the polypeptide is across
the membrane. Several lines of evidence support insertion of
SecA across the membrane, including protease protection of
SecA upon interaction with SecY (3, 4) and apparent periplasmic
exposure of SecA (5, 6). However, alternative interpretations of
these data have been proposed, suggesting that SecA may not
insert into the channel (7). Indeed, the x-ray structure of the
SecY channel suggests that the channel cannot accommodate a
SecA molecule (8). What is clear is that SecA undergoes
conformational changes that are coupled to its interaction with
ligands, and that domain movements driven by the ATPase cycle
are required to move polypeptide chains through the channel.
SecA exists in an equilibrium between dimeric and monomeric
states (9–11), with the monomeric state stabilized by interactions
with acidic phospholipids or the SecY complex (9, 12–14). A
synthetic signal peptide also induces dissociation of the dimer (9,
12). A SecA mutant that fails to dimerize retains significant
translocation activity (see ref. 9; E. Or and T.A.R., unpublished
data). These data suggest that the active form of SecA may be
monomeric. Further experiments indicate that the same ligands,
phospholipids, and signal peptides can induce additional con-
formational changes in SecA (11, 15).
Crystal structures of SecA from Bacillus subtilis and Myco-
bacterium tuberculosis show that it contains two domains that are
similar to the two RecA-like domains that form the ATPase site
of superfamily 1 and 2 helicases (16, 17). In helicases, such as
PcrA, the two RecA-like domains move relative to one another
during the ATPase cycle, generating domain movements that
translocate the helicase along nucleic acids (18). Mutagenesis of
residues in SecA (9, 19, 20) supports the idea that it uses a similar
mechanism to generate domain movements that are coupled to
polypeptide translocation.
SecA also contains the following three domains with no
similarity to any helicase domains: the preprotein crosslinking
domain (PPXD), helical wing domain (HWD), and helical
scaffold domain (HSD) (16, 17). How these domains can gen-
erate a promiscuous peptide-binding site is not clear from the
previous structures. We describe the crystal structure of B.
subtilis SecA in a monomeric state in which the PPXD, previ-
ously implicated in polypeptide binding, undergoes a dramatic
rigid body rotation. This conformational change opens a deep
groove in the protein, which is similar to the peptide-binding sites
in other proteins that interact with a diverse range of polypeptide
substrates. The open conformation may correspond to an acti-
vated state of SecA.
Methods
Protein Purification and Crystallization. Full-length B. subtilis SecA
was cloned into the plasmid pET19b, incorporating a prescission
protease cleavage site after the N-terminal histidine tag, and
expressed in BL21 cells. After purification with nickel–
nitrilotriacetic acid (Ni-NTA) agarose, the histidine tag was
cleaved. SecA was purified further with a MonoQ column and
dialyzed against 10 mM Hepes, pH 7.50.5 mM Tri(2-
carboxyethyl)phosphine. Crystals of SecA were grown by using
the hanging-drop method with a reservoir containing 100 mM
Hepes (pH 7–7.5), 250 mM magnesium acetate, and 7–12%
polyethylene glycol 8000. Crystals were frozen in reservoir
solution containing 10% butanediol.
Structure Determination. SecA crystals contain a single molecule
in the asymmetric unit and belong to the space group C2 with the
following cell dimensions: a  149.2 Å, b  107.9 Å, c  72.1 Å,
and   95.0°. Data were processed with HKL2000 (21). The
structure was determined by molecular replacement using the
program AMORE (22). The previously published structure of
SecA (1M6N), with residues 221–354 omitted, was used as a
search model. After refinement by using CNS, density modifica-
tion was carried out (23), and it yielded clear density for the
region corresponding to residues 221–354. After addition of a
model for this region, further cycles of manual rebuilding by
using the program O (24) and refinement by using CNS were
performed. The structure of ADP-bound SecA was also deter-
mined from crystals soaked in adenosine 5-[,-imido]triphos-
phate. No density for the  phosphate was seen in the electron-
density map, indicating that ADP (a contaminant in 5-[,-
imido]triphosphate) was bound.
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Maleimide Fluorescein Labeling and Chemical Crosslinking. Single
cysteine mutations (E234C or K824C) were introduced into N95
Escherichia coli SecA containing a C-terminal histidine tag and
lacking cysteines (C98S). Mutants were purified with nickel–
nitrilotriacetic acid (Ni-NTA) agarose, followed by a Superdex
200 gel-filtration column. We labeled 0.6 M SecA in 50 mM
Hepes, pH 750 mM KCl by addition of 63 M maleimide
fluorescein. After 3 min at 25°C, DTT was added to a concen-
tration of 330 mM. Samples were run on an SDSPAGE gel and
visualized under UV light. Crosslinking with 20 mM 1-ethyl-3-
(3-dimethylaminopropyl)carbodiimide was performed under
identical conditions for 10 min before quenching with 250 mM
glycine and SDS sample buffer. The following detergents were
used in labeling and crosslinking experiments: 1-myristoyl-2-
hydroxy-sn-glycero-3-[phospho-rac-(1-glycerol)], 1,2-dihep-
tanoyl-sn-glycero-3-phosphocholine, dodecyl maltoside, decyl
maltoside, octyl maltoside, octyl glucoside, CYMAL4, CY-
MAL6, lauryldimethylamine-N-oxide, digitonin, and SDS.
Large unilamellar vesicles were prepared from 70% 1,2-dioleoyl-
sn-glycerol-3-phosphoethanolamine and 30% 1,2-dioleoyl-sn-
glycerol-3-[phospho-rac-(1-glycerol)] (15) and added to a final
concentration of 2 mgml.
Results
Crystallization of SecA. Crystals of B. subtilis SecA that diffracted
to 2.2 Å were obtained, and the structure was solved by
molecular replacement by using parts of the published B. subtilis
SecA structure (16) as a search model. Most of the electron
density could be readily interpreted, and many regions desig-
nated in the previous structure as ‘‘unreliable’’ are well ordered.
The C-terminal 61 residues were disordered, although mass
spectrometry indicated that they were present in the crystallized
protein. The structure of ADP-bound SecA was also determined.
Crystallographic statistics are shown in Table 1.
Description of the Structure. As noted in refs. 16 and 17, the
ATPase domain of SecA is made up of two RecA-like folds
referred to as nucleotide-binding folds 1 and 2 (NBF1 and
NBF2) (Fig. 1). Similar to other RecA-like domains, they
Fig. 1. Structure of monomeric B. subtilis SecA. Monomeric B. subtilis SecA
is presented as a ribbon diagram. NBF1 is shown in yellow, NBF2 is shown in
blue, the PPXD is shown in orange, the HSD is shown in green, and the HWD
is shown in cyan. ADP is shown in a ball-and-stick representation. The images
were prepared by using MOLSCRIPT (40), RASTER3D (41), or SPOCK (available at
http:mackerel.tamu.eduspock).
Fig. 2. Contacts in different SecA crystal forms. (a) Ribbon diagram of the
previously determined B. subtilis SecA structure, which is likely to be the
physiological dimer (16). (b) The largest contact in the crystal lattice of
monomeric B. subtilis SecA. (c) The proposed M. tuberculosis SecA dimer (17).
Residues 757–768 in the HSD and the N terminus of SecA that are important
for dimerization of E. coli SecA are shown in red and yellow, respectively.
Table 1. Crystallographic statistics
Data set SecA (apo)* SecA (ADP)*
Resolution, Å 2.18 2.9
Unique reflections 58,197 25,014
II 28.37 (2.65) 20.93 (2.08)
Completeness, % 98.8 (97.7) 99.3 (94.0)
Rsym† 0.063 (0.516) 0.073 (0.479)
Rcryst,‡ % 24.0 (31.3) 22.8 (38.6)
Rfree,§ % 27.3 (33.5) 29.2 (45.2)
rms deviation bond angles, ° 1.1 1.3
rms deviation bond length, Å 0.007 0.008
Average B factor 56.1 61.5
Most favored angles,¶ % 90.5 88.3
Allowed angles,¶ % 8.8 10.4
Generously allowed angles,¶ % 0.7 1.3
*Values in parentheses refer to data in the highest-resolution shell (2.26–2.18
Å and 3–2.9 Å in the apo and ADP datasets, respectively).
†RsymhkliIi(hkl) I(hkl)hkliIi(hkl), where I(hkl) is the average intensity.
‡RcrysthklFobs kFcalchklFobs, where Fcalc and Fobs are the calculated and
observed structure factor amplitudes, respectively.
§Rfree is the same as Rcryst except that the summation is over randomly selected
reflections excluded from the refinement.
¶Defined by PROCHECK.
10938  www.pnas.orgcgidoi10.1073pnas.0401742101 Osborne et al.
contain a sheet of -strands, f lanked on either side by -helices.
The nucleotide-binding site is found at the interface between
NBF1 and NBF2, with both domains contributing residues that
are essential for catalysis (Fig. 1).
The HSD contains a long -helix extending from the end of
NBF2. At its C terminus, it forms part of a three-helix bundle,
which forms an interface with NBF1. The HWD is an insertion
into the three-helix bundle. It contains two -helices, but other
regions in the domain appear to be less ordered (high B factors).
The PPXD, containing -helices and -strands, emerges from
NBF1 and forms an interface with the HSD. The crystal
structure of SecA in the presence of magnesium–ADP is almost
identical to the nucleotide-free structure, but it shows some
small changes in side-chain conformations around the bound
nucleotide.
SecA Is Crystallized as a Monomer. In the previous B. subtilis SecA
structure, two SecA monomers pack head to tail in the crystal
lattice, likely representing the physiological dimer (16) (Fig. 2a).
An antiparallel dimer in solution is supported by fluorescence
resonance energy transfer experiments (11). E. coli SecA can be
converted to a monomeric species by mutation of residues in the
HSD or by deletion of the 11 N-terminal residues (ref. 9; E. Or
and T.A.R., unpublished data). These residues are at the dimer
interface (shown in color in Fig. 2a), supporting the physiological
relevance of the dimer seen in the previous crystal structure. The
interface of this dimer buries 5,442 Å2 (determined by using CNS
and a 1.4-Å probe radius) (23). The largest intermolecular
interface in our structure buries a much smaller area than the
physiological dimer (2,410 Å2; Fig. 2b), the crystal contacts are
different, and residues important for SecA dimerization are in a
minor crystal contact. In addition, the intersubunit distances
obtained from fluorescence resonance energy transfer experi-
ments in solution are not consistent with our structure being the
physiological dimer (11). All of these data suggest that we have
crystallized monomeric SecA.
The crystal packing in our structure is also different from that
observed for M. tuberculosis SecA. It has been proposed that the
M. tuberculosis SecA structure also represents a physiological
dimer, but its interface is different from that of the B. subtilis
SecA dimer (Fig. 2c) and it buries only 2,822 Å2 (17). Residues
that are important for dimerization of E. coli SecA are not
localized at this interface (Fig. 2c), suggesting that the M.
tuberculosis SecA structure also represents a monomeric state of
SecA.
Domain Movements in B. subtilis SecA. Comparison with the pre-
vious structures shows that monomeric B. subtilis SecA is essen-
tially identical in the NBF1 and NBF2 regions (Fig. 3); the
average difference (rms deviation) for the peptide backbone in
the NBFs (including residues 57–217 and 356–540) is 0.7 Å when
compared with dimeric B. subtilis SecA, and 0.92 Å when
compared with M. tuberculosis SecA (omitting residues in the
insert in NBF2 of M. tuberculosis SecA). In contrast, the other
domains have undergone large movements.
The most dramatic domain movement in monomeric B. subtilis
SecA is an 60° rigid body rotation of the PPXD (Fig. 3 and
Movie 1, which is published as supporting information on the
PNAS web site). The ‘‘hinge point’’ occurs around residues 226
and 348 in the two strands connecting the PPXD and NBF1. The
rms deviation for the -carbon atoms in the PPXD (including
residues 232–343) between monomeric B. subtilis SecA and M.
tuberculosis SecA is 1.7 Å. The region is essentially identical to
the dimeric B. subtilis domain, with deviations mostly in residues
declared as unreliable in the dimer structure. Rotation of the
PPXD results in the breaking of its ‘‘porous’’ interface with the
HSD and HWD (16) and the formation of a large groove
between these three domains (Fig. 3).
Together, the HWD and HSD undergo a rotation of 15°
relative to the same domains in the dimeric B. subtilis SecA (Fig.
3). Additionally, in the monomeric B. subtilis SecA, the HSD is
shifted toward NBF2 by 2 Å. Its overall fold is similar, with an
Fig. 3. Domain movements in monomeric SecA. Ribbon diagram of monomeric B. subtilis SecA in the open conformation (a) and of a single subunit of dimeric
B. subtilis SecA in the closed conformation (b). Color codes are as described for Fig. 1. The first and last helices in the PPXD are represented as cylinders to better
visualize the transition between the conformations. The arrows in a indicate the movements that are required to convert the open conformation to the closed
conformation. The side chains of residues 232 and 773 are shown in red in stick representation. Corresponding E. coli SecA residue numbers are given in
parentheses. These residues were mutated to cysteines in E. coli SecA, and the accessibility of residue 824 to a modification reagent was used to probe the
transition from the closed to the open conformation.
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rms deviation of 1.5 Å for superimposing it with the same region
of dimeric SecA. There is a short stretch of 310 helix between
residues 599 and 601 in the monomeric B. subtilis SecA, possibly
indicating that this region may be able to accommodate further
conformational changes. Given that the drastic conformational
changes in monomeric B. subtilis SecA occur in the absence of
any changes in NBF1 and NBF2, they are unlikely to represent
nucleotide-dependent movements.
Potential Interaction Sites for Substrate and Binding Partners. The
movement of PPXD opens a large groove,10 Å deep and 15 Å
wide, between the PPXD and the HSDHWD, which is an
excellent candidate for a peptide-binding site (groove 1; red in
Fig. 4a). It is similar to peptide-binding grooves in other proteins,
such as calmodulin (Fig. 4b) (25) and Hsp70 (Fig. 4c) (26), which
interact with diverse substrates. Groove 1 contains numerous
charged and polar residues that might interact with the peptide
backbone. It also contains two large pockets, one in the HSD and
HWD (pocket H) and the other in the PPXD (pocket P; Fig. 4
d and e), which might accommodate side chains of the peptide
substrate.
There is also a shallow groove extending across the HSD and
part of NBF1 adjacent to groove 1 (groove 2; blue in Fig. 4a)
(16). The upper side of the groove is lined by two -strands
connecting the PPXD and NBF1. In dimeric B. subtilis SecA, this
groove was occupied partially by the C-terminal residues, 794–
798 (16), but in monomeric B. subtilis SecA, the equivalent
region is disordered, and therefore, the groove is accessible.
E. coli SecA Can Adopt a Monomeric, Open Conformation. To deter-
mine whether E. coli SecA can adopt an open conformation in
solution, we tested the accessibility of residues in the interface
between the PPXD and HSD to the thiol-modifying reagent
maleimide fluorescein. Based on the B. subtilis SecA structures,
a cysteine introduced at position 824 of E. coli SecA (773 in B.
subtilis SecA) should be buried in the closed, but not the open,
conformation (Fig. 3). A cysteine at position 234 of E. coli SecA
(232 in B. subtilis SecA) should be accessible in both states. As
expected, in the presence of SDS, both cysteines were labeled
efficiently by fluorescein maleimide (Fig. 5a, lanes 12 and 16),
whereas a cysteine-less mutant (N95 SecA, C98S) was not
labeled (lane 14). In buffer alone, the cysteine at position 824 was
not labeled (lane 1), indicating that the ground state of SecA is
a closed conformation. In the presence of liposomes, this residue
was labeled efficiently (lane 2), suggesting that lipid-associated
SecA adopts an open conformation. A similar conformational
change was induced by the addition of 50–250 mM Mg2 (lanes
3–6) or various nondenaturing detergents (Fig. 5c, lanes 2–10),
an exception being digitonin, which is likely the mildest tested
detergent (lane 11). These results indicate that SecA can adopt
an open conformation in solution when not constrained in a
crystal lattice.
In parallel to the experiments described above, we determined
the oligomeric state of SecA by chemical crosslinking (9). In
Fig. 4. Potential ligand-binding sites in monomeric B. subtilis SecA. (a) A
surface representation of SecA showing the surface grooves 1 and 2 in red and
blue, respectively. (b) Surface representation of calmodulin with bound pep-
tide shown in green as an -carbon trace (25). (c) Surface representation of
Hsp70, with the C terminus occupying the peptide-binding groove shown in
green as an -carbon trace (26). (d and e) Surface representations of groove 1,
showing the location of pockets H and P, respectively. The surface is rendered
transparent, and the underlying peptide backbone is color-coded as described
for Fig. 1.
Fig. 5. E. coli SecA can adopt an open conformation in solution. (a) SecA
containing single cysteines at positions 824 or 234, or a mutant lacking
cysteines (no cys), were labeled with maleimide fluorescein in the presence of
the indicated additions. When nucleotide (0.25 mM) was added, 0.5 mM
MgCl2 was also included. The samples were separated by SDSPAGE and
visualized under UV light. In the lane labeled quenchSDS, the quenching
reagent, either DTT or glycine, was added before labeling or crosslinking. (b)
In parallel, samples were crosslinked with 1-ethyl-3-(3-dimethylaminopro-
pyl)carbodiimide, separated by SDSPAGE, and stained with Coomassie blue.
The position of dimer crosslinks is indicated. (c) Modification reactions with
SecA containing a cysteine at position 824 were performed as in a in the
presence of 1-myristoyl-2-hydroxy-sn-glycero-3-[phospho-rac-(1-glycerol)]
(MLPG, 0.1 mM); 1,2-diheptanoyl-sn-glycero-3-phosphocholine (DHPC, 4.2
mM); dodecyl maltoside (DDM, 0.6 mM); decyl maltoside (DM, 3.6 mM); octyl
maltoside (OM, 39 mM); octyl glucoside (OG, 36.4 mM); CYMAL4 (15.2 mM);
CYMAL6 (1.12 mM); lauryldimethylamine-N-oxide (LDAO, 2 mM); digitonin
(1%); or SDS (0.5%). (d) In parallel, samples were crosslinked with 1-ethyl-3-
(3-dimethylaminopropyl)carbodiimide.
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buffer alone, crosslinking with 1-ethyl-3-(3-dimethylaminopro-
pyl)carbodiimide led to the appearance of several high-
molecular-weight species, diagnostic of the dimeric state of SecA
(Fig. 5b, lane 1) (9). The addition of lipid, Mg2, or nondena-
turing detergents, which efficiently converted SecA to an open
conformation (Fig. 5 a and c), also caused dissociation of the
SecA dimer, as indicated by the loss of high-molecular-weight
crosslinks (Fig. 5 b, lanes 2 and 3–6, and d, lanes 2–10). Digitonin
was ineffective in dimer dissociation (Fig. 5d, lane 11), and 250
mM NaCl caused partial dissociation of the dimer and only
inefficient labeling with maleimide fluorescein. Several of the
detergents used, such as 1-myristoyl-2-hydroxy-sn-glycero-3-
[phospho-rac-(1-glycerol)] (12) and dodecyl maltoside (9), as
well as high salt concentrations have been demonstrated (10, 11)
to cause dissociation of the SecA dimer. Thus, there is a general
correlation between conversion of SecA into an open confor-
mation and dissociation of the dimer into monomers.
Potential Domain Interactions During the ATPase Cycle. One ADP
molecule is bound in the cleft between NBF1 and NBF2 (Fig. 1)
(16, 17), and there is no evidence for a second ATP-binding site
(proposed in ref. 27). Comparison with the structure of PcrA
bound to a nonhydrolysable ATP analogue (18) shows that, for
ATP-hydrolysis to occur, NBF2 must move relative to NBF1
such that the essential and conserved arginine residue in helicase
motif 6 (9, 28) of SecA can coordinate the -phosphate of ATP
(Fig. 6a). Relative movement of the two NBFs is supported by
experiments showing that the linker between them becomes
protease-resistant in the presence of nucleotide (29). The reori-
entation of NBF1 and NBF2 might be propagated to other
domains, resulting in movement of the polypeptide substrate.
Conversely, conformational changes in other domains may affect
the ATPase cycle. The strand leading from NBF1 to the PPXD
emerges from the Walker B motif (Fig. 6b), and the strand
leading from the PPXD to NBF1 is connected to the strand
between the Walker A and B strands. Both strands connecting
NBF1 to the PPXD line groove 2.
Many superactive SecA mutations that suppress multiple
mutations in SecY channel components (30) and the PrlD
mutations that suppress signal peptide defects (31, 32) map to
residues that are close to the nucleotide-binding site (Fig. 6c).
However, the superactive SecA mutation (H309Y; residue 288 in
B. subtilis) is found in pocket P, and the A373V mutation
(residue 353 in B. subtilis), identified both as a PrlD and a
superactive SecA mutant, is found in groove 2, attesting to the
importance of these sites and interdomain communication.
Discussion
We have determined the crystal structure of SecA in a mono-
meric, open conformation in which movement of the PPXD,
HSD and HWD generates a deep groove on the surface of the
protein. We demonstrate that E. coli SecA adopts a similar open
conformation in solution under various conditions. Most signif-
icantly, the interaction of SecA with lipids, which is likely to be
an early step during protein translocation, induces the open
conformation. Fluorescence resonance energy transfer and Trp
fluorescence experiments have also demonstrated movement of
the PPXD and HSD upon interaction with lipid (11, 15). Trp-775
in the HSD of E. coli SecA moves from a buried environment to
a solvent-exposed environment upon binding lipid or signal
peptide. In the B. subtilis dimeric structure, this Trp residue is
buried in the hydrophobic core of the HSD, whereas in the
monomeric B. subtilis SecA structure, the residue is in a more
polar environment in the close proximity of three water mole-
cules.
Lipid binding not only induces an open conformation of SecA
but also dissociates the SecA dimer (9, 12, 13). The observations
that a monomeric SecA mutant retains significant translocation
activity (9) and that acidic phospholipids are essential for
efficient protein translocation (33) indicate that the monomeric
open conformation represents an important, activated state of
SecA. It is unclear whether the SecA dimer could adopt an open
conformation, but it has been reported that the dimer can adopt
two different conformations (10). However, because most con-
ditions that induce an open conformation also dissociate the
dimer, it appears that the monomer can undergo the conforma-
tional change to the open state more readily.
The large groove (groove 1) between the PPXD, HSD and
HWD is an excellent candidate for a peptide-binding site.
Crosslinking experiments indicate that the PPXD is in close
proximity to bound preprotein (34), and mutagenesis of residues
in the PPXD further supports a role for it in polypeptide binding
(35). Groove 1 has similar dimensions to those seen in other
proteins that interact with a wide range of peptide substrates,
including the Hsp70 family (26), calmodulin (36), and OppA
(37). In these cases, the walls of a deep groove embrace the
Fig. 6. The ATPase site and mutations affecting SecA function. (a) The
Walker A motifs of ADP-bound SecA and ATP-bound PcrA are superimposed.
The Walker A and B motifs and motif 6 of monomeric B. subtilis SecA are
shown in color, and the equivalent motifs in PcrA are shown in gray (18).
Arginine residues in motif 6 are shown in stick representation, and a magne-
sium ion bound to SecA is shown as a green sphere. The ATP bound to PcrA and
the ADP bound to SecA are shown in a stick representation in gray and light
blue, respectively. The phosphorus atom of the -phosphate of ATP bound to
PcrA is shown in red. (b) A view of the SecA ATPase site showing that the
Walker B motif (red) is connected to the PPXD via a -strand (gray). The
-strand (blue) that leads from the PPXD back to NBF1 is connected to the
strand between the Walker A (black) and B motifs. NBF2 is omitted for clarity,
and the remaining domains are color-coded as described for Fig. 1. The
aspartate residue in the Walker B motif and ADP are shown in stick represen-
tation. (c) SecA mutations that suppress mutations in SecY channel compo-
nents are shown in yellow, and PrlD mutations that suppress signal sequence
mutations are shown in cyan on a backbone representation of monomeric B.
subtilis SecA. Residues identified in both screens are shown in green. ADP is
shown as a stick representation.
Osborne et al. PNAS  July 27, 2004  vol. 101  no. 30  10941
BI
O
CH
EM
IS
TR
Y
polypeptide, and its side chains are accommodated in large
pockets. The two pockets (P and H) in SecA are large enough to
accommodate bulky side chains of the substrate. They are lined
mostly, but not exclusively, by polar and charged residues.
Structural analysis of OppA demonstrates how such pockets can
accommodate each of the 20-aa side chains (37): the pockets are
filled with water molecules that are displaced, depending on the
size of the side chain. A similar principle is also used by the
nonanchor positions of the MHC I peptide-binding site (38).
Based on crosslinking experiments, SecA is likely to change its
affinity for peptide substrate during the ATPase cycle (34, 39).
A high-affinity state could be induced by nucleotide-dependent
conformational changes in groove 1 such that, in the high-
affinity state, the groove would close around the peptide.
Binding and release cycles could be coupled to other confor-
mational changes that push the polypeptide into the SecY
channel. It has been proposed (16) that groove 2 may form a
polypeptide- or signal sequence-binding site. Alternatively, or in
addition, this shallow, conserved groove may bind to the cyto-
plasmic loops in SecY (8). The structures of SecA now provide
a basis to address some of these ideas.
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